3 ·Filed Apr 1, 2026
Form 3 — initial insider ownership statement
Actionable Insight • Neutral
Monitor for subsequent Form 4 or amended Form 3 filings that may disclose actual share quantities and transaction details. The lack of disclosed share numbers limits immediate trading relevance.
Price Chart
Loading chart...
Executive Summary
Marquet Magda, affiliated with ALTHEADX INC., filed a Form 3 disclosing initial beneficial ownership of First Tracks Biotherapeutics, Inc. (TRAX) securities as of April 1, 2026. The filing is a routine ownership disclosure and does not specify the number or value of shares held.
Key Facts
- Form 3 filed by Marquet Magda indicating initial beneficial ownership of TRAX securities
- Reporting person is affiliated with ALTHEADX INC., headquartered in San Diego, WA
- Issuer: First Tracks Biotherapeutics, Inc. (TRAX), a biopharma company incorporated in Delaware
- No specific share amounts, percentages, or financial values are disclosed in the available filing content
- Company formerly known as Biopharma Company, Inc., changed name on October 10, 2025
Financial Impact
undisclosed amount
ownership concentrationinsider ownership
Risk Factors
- Insufficient data to assess potential insider activity or ownership concentration
- Possible future disclosures could reveal material positions or transactions
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001631486-26-000004 |
| Document: 0001631486-26-000004-index.html | 0001631486-26-000004 |
| Document: 0001631486-26-000004.txt | 0001631486-26-000004 |
20 reports for TRAX
80% Hit rate @ T+1 Went positive at some point 4 of 5 best @ T+5▲ +30.21%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | S-1 | $43.80 | awaiting T+1 | — | $44.05 (+0.57%) |
Oct 20, 2026 5d ago | 8-K | $42.77 $43.14 | ▲ +0.87% | ▲ +2.05% | $44.05 (+2.99%) |
Oct 15, 2026 10d ago | 8-K | $34.46 $36.28 | ▼ −5.28% | ▼ −4.86% | $44.05 (−27.83%) |
Oct 15, 2026 11d ago | Press Release | $36.04 $34.46 | ▲ +4.38% | ▲ +3.28% | $44.05 (−22.23%) |
Oct 13, 2026 13d ago | 8-K | $31.68 $34.13 | ▲ +7.73% | ▲ +8.81% | $44.05 (+39.05%) |
Aug 12, 2026 10w ago | 8-K | $44.03 $44.04 | ▲ +0.02% | ▲ +0.22% | $44.05 (+0.05%) |
Aug 12, 2026 10w ago | Press Release | $44.03 $44.04 | ▲ +0.02% | ▲ +0.22% | $44.05 (+0.05%) |
Aug 7, 2026 11w ago | 3/A | $47.92 $46.75 | ▼ −2.44% | ▼ −2.12% | $44.05 (−8.08%) |
Jun 22, 2026 17w ago | 8-K | $17.78 $16.69 | ▼ −6.13% | ▼ −6.08% | $44.05 (+147.75%) |
May 14, 2026 23w ago | 8-K | $16.90 $17.79 | ▲ +5.27% | ▲ +5.33% | $44.05 (+160.65%) |
Showing 10 of 20
US Market Status
Market Closed — Opens in 20m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers